what-are-treatments-for-lyme-disease
Lyme Science Blog
Nov 12

Lyme Disease Treatment: What Works—and What Happens When Symptoms Persist

Comments: 3
Like
Visited 457 Times, 1 Visit today

Lyme Disease Treatment: What Works—and What Happens When Symptoms Persist

Lyme disease treatment can be straightforward—or unexpectedly complex when symptoms persist.

Treatments for Lyme disease vary based on the stage of infection, symptom pattern, duration of illness, and the presence of coinfections.

Some patients are diagnosed early and recover quickly. Others are diagnosed later, after symptoms have spread or changed, making treatment decisions more complex.

Key Question: What happens when Lyme disease symptoms don’t resolve after standard treatment?

Two major medical organizations—the Infectious Diseases Society of America (IDSA) and the International Lyme and Associated Diseases Society (ILADS)—offer different perspectives on how Lyme disease should be treated, especially when symptoms persist.


Quick Answer: What Are Treatments for Lyme Disease?

The main treatments for Lyme disease include oral antibiotics, intravenous antibiotics in selected cases, evaluation for coinfections, supportive care, and individualized follow-up based on response.

Common antibiotics used in Lyme disease treatment include:

  • Doxycycline
  • Amoxicillin
  • Cefuroxime
  • Azithromycin
  • Clarithromycin
  • Minocycline

The optimal treatment plan depends on the patient—not just the diagnosis.


IDSA Treatment Approach

The Infectious Diseases Society of America (IDSA) recommends a defined course of antibiotics, typically lasting 10 to 28 days depending on the presentation.

Under this approach, lingering symptoms after treatment are generally attributed to immune or inflammatory effects rather than ongoing infection.

Additional antibiotic therapy is usually not recommended, except in specific situations such as Lyme arthritis.

This model may work well for patients diagnosed early. However, it may not fully address patients with delayed diagnosis, neurologic symptoms, or persistent multisystem illness.


ILADS Treatment Approach

The International Lyme and Associated Diseases Society (ILADS) recommends an individualized treatment approach.

ILADS recognizes that early Lyme disease may respond to a short course of antibiotics. But in patients with disseminated infection or persistent symptoms, treatment duration may need to be adjusted based on clinical response.

Clinical Point: There is no one-size-fits-all treatment for Lyme disease. Care often requires reassessment and adjustment over time.

This approach places greater emphasis on clinical judgment, especially when symptoms do not resolve as expected.


Why Lyme Disease Treatment Can Be Complex

Lyme disease does not follow a single pattern. Some patients never recall a tick bite. Others never develop a rash. Symptoms may evolve over time, affecting multiple systems.

Factors that can influence treatment include:

  • Delayed diagnosis
  • Stage of infection
  • Neurologic, cardiac, or arthritic involvement
  • Differences in immune response
  • Incomplete early treatment
  • The presence of tick-borne coinfections

When symptoms persist, it is important to reassess the diagnosis, treatment response, and whether additional factors are contributing.


Antibiotic Options for Lyme Disease

Antibiotic therapy remains the primary treatment for Lyme disease. Depending on the clinical situation, treatment may include oral, intravenous, or intramuscular antibiotics.

Oral antibiotics are commonly used for early disease and for many patients with persistent symptoms. Intravenous antibiotics may be considered for neurologic involvement, cardiac complications, or severe arthritis.

In some cases, clinicians may consider:

  • Sequential antibiotic therapy
  • Combination regimens
  • Adjustments in dosing
  • Retreatment when symptoms persist

Persistent or relapsing symptoms should prompt a closer look at the overall clinical picture, not just treatment duration.

For a broader discussion, see persistent Lyme disease.


Supportive Care During Treatment

Supportive care plays an important role, especially in patients with fatigue, pain, or neurologic symptoms.

Strategies may include:

  • Rest and pacing activity
  • Avoiding alcohol during treatment
  • Limiting processed sugars
  • Exercise as tolerated
  • Stress management
  • Monitoring symptoms closely

Patients should also be counseled about the Jarisch-Herxheimer reaction, a temporary worsening of symptoms that may occur after starting antibiotics.

For more detail, see Herxheimer reaction in Lyme disease.


Managing Treatment Risks

Antibiotics can have side effects, including gastrointestinal symptoms, allergic reactions, and changes in laboratory values.

One important complication is Clostridioides difficile infection, which can cause significant diarrhea.

Some studies suggest probiotics may reduce this risk, though this should be discussed with a clinician.


When Symptoms Persist After Treatment

Some patients continue to experience fatigue, pain, cognitive symptoms, or neurologic issues after initial treatment.

This does not always mean the same process is ongoing—and it should not be dismissed without evaluation.

Key questions include:

  • Was treatment started early or late?
  • Was there any improvement with therapy?
  • Could coinfections be present?
  • Are symptoms fluctuating or evolving?

For additional context, see post-treatment Lyme disease syndrome (PTLDS) and Lyme disease recovery timeline.


Shared Decision-Making Matters

Treatment decisions should involve collaboration between the patient and clinician.

This is especially important when symptoms persist, diagnosis was delayed, or treatment response is unclear.

Lyme disease treatment is not about following a fixed rule. It is about understanding the patient in front of you.


Clinical Perspective

The challenge in Lyme disease treatment is not choosing between guidelines. It is recognizing which patient fits which situation.

Some recover quickly with standard therapy. Others require deeper evaluation of persistent symptoms, coinfections, and neurologic or immune involvement.

The goal is not longer treatment or shorter treatment. The goal is appropriate treatment.


Related Reading


References:
  1. Bron GM et al. Context matters: Contrasting behavioral and residential risk factors for Lyme disease. Ticks Tick Borne Dis. 2020;11(6):101515.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

SymptomsTestingCoinfectionsRecoveryPediatricPrevention

Related Posts

3 thoughts on “Lyme Disease Treatment: What Works—and What Happens When Symptoms Persist”

  1. After I got a tick bite I had blood work done in 2020 and told me I was all set with good results of Lyme disease. I was tired and and in pain for awhile on and off , so covid came and I waited till 2022 to have the test again and it came back with a positive result of Lyme and I got the red bullseye’s all over, now I’m waiting to get in for my doctor appointment. They missed some of the results in 2020 ,it showed present for Lyme

Leave a Comment

Your email address will not be published. Required fields are marked *